PER - Megathread, page-54

Biotech's seem like the only shining light across ASX specs right now as most other sectors are struggling.

The timing of this, while fortuitous, is very welcome

Full recruitment is only a matter of weeks away & then the 26 week treatment window clock begins counting down for that final patient.

As more & more eyes come across to PER, the re-rate continues in earnest and powers through those levels.

Remember, we were as high as 35c in late 2021 before the disasterous CR.

We are now at the back end of the Pivotal P2B trial with the headline numbers only a few months away